 Sertraline
"Sertraline" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective serotonin uptake inhibitor that is used in the treatment of depression.
| Descriptor ID |
D020280
|
| MeSH Number(s) |
D02.092.705.800 D02.455.426.559.847.638.845.800 D04.615.638.845.800
|
| Concept/Terms |
Zoloft- Zoloft
- Altruline
- Parke Davis Brand of Sertraline Hydrochloride
- Lustral
- Pfizer Brand of Sertraline Hydrochloride
- Roerig Brand of Sertraline Hydrochloride
Apo-Sertraline- Apo-Sertraline
- Apo Sertraline
- Apotex Brand of Sertraline Hydrochloride
Aremis- Aremis
- Esteve Brand of Sertraline Hydrochloride
- Besitran
Sealdin- Sealdin
- Lacer Brand of Sertraline Hydrochloride
Gladem- Gladem
- Boehringer Ingelheim Brand of Sertraline Hydrochloride
Novo-Sertraline- Novo-Sertraline
- Novo Sertraline
- Novopharm Brand of Sertraline Hydrochloride
ratio-Sertraline- ratio-Sertraline
- ratio Sertraline
- Ratiopharm Brand of Sertraline Hydrochloride
Rhoxal-sertraline- Rhoxal-sertraline
- Rhoxal sertraline
- Rhoxalpharma Brand of Sertraline Hydrochloride
Gen-Sertraline- Gen-Sertraline
- Gen Sertraline
- Genpharm Brand of Sertraline Hydrochloride
|
Below are MeSH descriptors whose meaning is more general than "Sertraline".
Below are MeSH descriptors whose meaning is more specific than "Sertraline".
This graph shows the total number of publications written about "Sertraline" by people in this website by year, and whether "Sertraline" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 | | 1997 | 0 | 1 | 1 | | 1999 | 0 | 1 | 1 | | 2006 | 0 | 2 | 2 | | 2007 | 1 | 0 | 1 | | 2008 | 1 | 1 | 2 | | 2009 | 0 | 1 | 1 | | 2010 | 1 | 0 | 1 | | 2011 | 1 | 0 | 1 | | 2012 | 1 | 0 | 1 | | 2013 | 4 | 1 | 5 | | 2014 | 3 | 1 | 4 | | 2015 | 2 | 1 | 3 | | 2017 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Sertraline" by people in Profiles.
-
Bingham KS, Rothschild AJ, Mulsant BH, Whyte EM, Meyers BS, Banerjee S, Szanto K, Flint AJ. The Association of Baseline Suicidality With Treatment Outcome in Psychotic Depression. J Clin Psychiatry. 2017 Sep/Oct; 78(8):1149-1154.
-
Abi Zeid Daou M, Boyd BD, Donahue MJ, Albert K, Taylor WD. Frontocingulate cerebral blood flow and cerebrovascular reactivity associated with antidepressant response in late-life depression. J Affect Disord. 2017 06; 215:103-110.
-
Davies SJ, Mulsant BH, Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Kirshner MM, Sorisio D, Pollock BG, Bies RR. The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD. Clin Pharmacokinet. 2015 Nov; 54(11):1161-8.
-
Østergaard SD, Rothschild AJ, Flint AJ, Mulsant BH, Whyte EM, Vermeulen T, Bech P, Meyers BS. Establishing the cut-off score for remission and severity-ranges on the Psychotic Depression Assessment Scale (PDAS). J Affect Disord. 2016 Jan 15; 190:111-4.
-
Bingham KS, Whyte EM, Meyers BS, Mulsant BH, Rothschild AJ, Banerjee S, Flint AJ. Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression. Am J Geriatr Psychiatry. 2015 Dec; 23(12):1270-5.
-
Rynn MA, Walkup JT, Compton SN, Sakolsky DJ, Sherrill JT, Shen S, Kendall PC, McCracken J, Albano AM, Piacentini J, Riddle MA, Keeton C, Waslick B, Chrisman A, Iyengar S, March JS, Birmaher B. Child/Adolescent anxiety multimodal study: evaluating safety. J Am Acad Child Adolesc Psychiatry. 2015 Mar; 54(3):180-90.
-
Mancino MJ, McGaugh J, Chopra MP, Guise JB, Cargile C, Williams DK, Thostenson J, Kosten TR, Sanders N, Oliveto A. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms. J Clin Psychopharmacol. 2014 Apr; 34(2):234-9.
-
Davies SJ, Mulsant BH, Flint AJ, Rothschild AJ, Whyte EM, Meyers BS. Differential impact of anxiety symptoms and anxiety disorders on treatment outcome for psychotic depression in the STOP-PD study. Compr Psychiatry. 2014 Jul; 55(5):1069-76.
-
Østergaard SD, Meyers BS, Flint AJ, Mulsant BH, Whyte EM, Ulbricht CM, Bech P, Rothschild AJ. Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account. J Affect Disord. 2014 May; 160:68-73.
-
Piacentini J, Bennett S, Compton SN, Kendall PC, Birmaher B, Albano AM, March J, Sherrill J, Sakolsky D, Ginsburg G, Rynn M, Bergman RL, Gosch E, Waslick B, Iyengar S, McCracken J, Walkup J. 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS). J Am Acad Child Adolesc Psychiatry. 2014 Mar; 53(3):297-310.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|